Pathologic Staging (pTNM, AJCC 8th Edition)

CAP Approved Gynecologic • Uterine Sarcoma 4.0.0.0

TNM Descriptors (required only if applicable) (select all that apply)

___ r (recurrent)

___ y (posttreatment)

For all sarcomas excluding adenosarcoma (including Leiomyosarcoma, Endometrial Stromal Sarcoma, and Undifferentiated Endometrial Sarcoma/Uterine Sarcoma)

Primary Tumor (pT)

___ pTX: Primary tumor cannot be assessed

___ pT0: No evidence of primary tumor

___ pT1: Tumor is limited to the uterus

___ pT1a: Tumor 5 cm or less in greatest dimension

___ pT1b: Tumor more than 5 cm

___ pT2: Tumor extends beyond the uterus, within the pelvis

___ pT2a: Tumor involves adnexa

___ pT2b: Tumor involves other pelvic tissues

___ pT3: Tumor infiltrates abdominal tissues

___ pT3a: Tumor infiltrates abdominal tissues in one site

___ pT3b: Tumor infiltrates abdominal tissues in more than one site

___ pT4: Tumor invades bladder or rectum

For Adenosarcoma 

Primary Tumor (pT)

___ pTX: Primary tumor cannot be assessed

___ pT0: No evidence of primary tumor

___ pT1: Tumor limited to the uterus

___ pT1a: Tumor limited to the endometrium/endocervix

___ pT1b: Tumor invades to less than half of the myometrium

___ pT1c: Tumor invades one half or more of the myometrium

___ pT2: Tumor extends beyond the uterus, but within the pelvis

___ pT2a: Tumor involves adnexa

___ pT2b: Tumor involves other pelvic tissues

___ pT3: Tumor infiltrates abdominal tissues

___ pT3a: Tumor infiltrates abdominal tissues in one site

___ pT3b: Tumor infiltrates abdominal tissues in more than one site

___ pT4: Tumor invades bladder and/or rectum

For All Sarcomas

Regional Lymph Nodes (pN)

___ pNX: Regional lymph nodes cannot be assessed

___ pN0: No regional lymph node metastasis

___ pN0(i+): Isolated tumor cells in regional lymph node(s) no greater than 0.2 mm

___ pN1: Regional lymph node metastasis

Distant Metastasis (pM) (required only if confirmed pathologically in this case)

___ pM1: Distant metastasis (excluding adnexa, pelvic and abdominal tissues)

Specify site(s), if known: ______________________________          

Uterine Sarcoma CAP 4.0.0.0 summary of pTNM changes AJCC 7th to 8th edition

1. Exactly 50% myometrial invasion for adenosarcoma now specified as pT1c
2. New pN0(i+) category for isolated tumor cells

Gynecologic

Comments

Click here to leave feedback